These results establish a novel role for MCL1 in regulating mTORC1 signaling that seems to be a unique feature of MCL1 not shared with the closely related anti-apoptotic proteins Bcl-2 and Bcl-xL and suggest that it is a general phenomenon, not confined to a cell model or cancer entity. Here, PROS1 is linked to cancer.